Breastfeeding choices for cancer patients: insights from the POSITIVE trial

In this interview, Fedro Peccatori (Istituto Europeo di Oncologia, Milan, Italy) discusses the POSITIVE trial, which is assessing the impact on women with Stage I–III hormone receptor-positive breast cancer taking a break from endocrine treatment to breastfeed. He highlights the importance of discussing breastfeeding with pregnant breast cancer survivors in prenatal counseling and concludes by discussing future work that needs to be done to understand the long-term impact of pausing treatment to breastfeed. What factors or conditions should be considered when recommending breastfeeding for breast cancer patients post-treatment? Any woman who wishes to breastfeed after breast cancer should be supported...